Procos fields expanded team for CPhI Worldwide
Press Release | Procos S.p.A.
SEPTEMBER 24, 2015
Procos will share stand D31 in Hall 12 at Madrid’s IFEMA center with its mother company, CBC Co., Ltd, staffed by an international team from Italy, other EU countries, the USA, Japan and India, reflecting its worldwide operations and recent expansion, with a workforce now numbering more than 270 worldwide.
Expanded development and manufacturing
A highlight of the stand will be a beautiful 3-D ‘georama’ model of the new Procos facility at Cameri. This will provide a 30 per cent expansion in manufacturing capacity, up to 450m3, as well as new technology platforms to enable more innovative and creative solutions for demanding markets like oncology.
Procos is nearing the end of a development project to created the new 4000 m2 manufacturing facility and development workshop, scheduled for completion in Autumn 2015. The new workshop is a central element in the company’s overall investment and growth strategy, focusing on its principle markets on enhanced APIs and generics.
World API markets
“Our combined team and displays at CPhI Madrid will sends a strong message about our plans to bolster our new generic APIs pipeline for world markets and the strategic importance of the new workshop,” said Kingo Yamashita, head of Procos’ Sales & Marketing Division.
“GMP manufacture of generics, together with our custom synthesis capabilities, are key elements in our strategy to drive continuous growth both in capacity and technology for high potency APIs,” said Mr. Yamashita.
Procos S.p.A. is an Italian Contract Research and Manufacturing Organization (CRO, CMO) that specializes in development, scale-up and production of APIs and cGMP advanced intermediates for the pharmaceutical industry.
Procos is an important member of the international CBC Group, headquartered in Japan. This network provides Procos with global reach, reinforced with subsidiary sales offices in the USA, Slovakia, Germany and India.
Over 70 years, Procos has built up a comprehensive range of technologies and capabilities to provide high quality products and services that have been widely accepted in worldwide pharmaceutical markets. It continuously develops and adds unique generic APIs and key intermediates to its product portfolio.
Procos’ two core business sectors are the development and supply of APIs and GMP advanced intermediates along with contract manufacturing services.
Procos manufactures more than 30 products, mostly under uniquely designed synthetic methods and under strict regulatory compliance management. In contract manufacturing, Procos provides related services for the pharmaceutical industry acting as a CRO/CMO for custom synthesis on exclusive base, supporting customer from early clinical stage up to full -scale commercial production. Development services include IP analysis expertise and effective patent challenge skills.
Innovation is a driving force of Procos activity. The company’s products are based on patented technologies and cost-effective processes. Procos chemistry expertise is focused on the most complex organic reactions, including organo-metallic catalysis, multi-catalytic hydrogenation, Enantioselective and hazardous chemistry.
About CPhI 2015
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing, creating opportunities for delegates and exhibitors to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gaining insights on latest industry trends.
Now in its 26th year, the 2015 event is a three-day event opening October 13 at IFEMA, Feria de Madrid. Last year’s show in Paris attracted almost 36,500 delegates and 2,500 exhibitor companies from more than 150 countries worldwide.
The CPhl Worldwide show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: www.cphi.com/home
Kingo Yamashita, Sales & Marketing Director, Procos SpA
Tel: +39 0321 642211